Akèy › Maladi kadyovaskilè › Kalifòni › San Francisco
Etid klinik pou Maladi kadyovaskilè nan San Francisco, CA
18 etid pou Maladi kadyovaskilè ap chèche patisipan nan sit nan ak bò kote San Francisco (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
Gauging Outcomes of Total Milk Ingestion on Lipid and gControl
Ap rekriteVolontè an sante akeyi
- UCSF Medical Center at Parnassus, San Francisco
ELEVATE-HFpEF Clinical Study
Ap rekrite
- Sutter Health Hospital, San Francisco
kTMP-Enhanced Motor Rehabilitation for Chronic Stroke Recovery (KULMINATE) Pilot
Ap rekrite
- UCSF Mission Bay- Sandler Neurosciences Center, San Francisco
Transcatheter Mitral Valve Replacement With the Medtronic Intrepid™ TMVR System in Patients With Severe Symptomatic Mitral Regurgitation.
Ap rekrite
- Kaiser Permanente San Francisco Medical Center, San Francisco
An Open Label Extension (OLE) Study (Following Completion of CTQJ230A12301) to Evaluate Long-term Safety and Tolerability of Pelacarsen (TQJ230)
Ap rekriteFaz 3
- UCSF, San Francisco
A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event
Ap rekriteFaz 3
- Research Site, San Francisco
Secondhand Tobacco Smoke and Cardiovascular Disease
Ap rekriteFaz 4
- San Francisco Veterans' Affairs Medical Center, San Francisco
Study to Evaluate Safety, Tolerability and Efficacy of Inclisiran in Children With Homozygous Familial Hypercholesterolemia
Ap rekriteFaz 3
- UC San Francisco Medical Center, San Francisco
Virtual Care Strategies to Improve Participation in Cardiac Rehabilitation Among Veterans
Ap rekrite
- San Francisco VA Medical Center, San Francisco, CA, San Francisco
PROACTIVE-HF-2 Trial Heart Failure NYHA Class II and III
Ap rekrite
- UCSF Medical Center, San Francisco
Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in Patients With Advancing Heart Failure
Ap rekrite
- University of California at San Francisco, San Francisco
Study to Evaluate Efficacy and Safety of Inclisiran in Children With Heterozygous Familial Hypercholesterolemia
Ap rekriteFaz 3
- UC San Francisco Medical Center, San Francisco
- UC San Francisco Medical Center, San Francisco
The EMPOWER Trial - The Carillon Mitral Contour System® in Treating Heart Failure With FMR
Ap rekrite
- University of California- San Francisco, San Francisco
Patient Care Outreach, Navigation, Technology and Support 2.0
Ap rekrite
- Zuckerberg San Francisco General Hospital, San Francisco
- University of California, San Francisco, San Francisco
Achieving Chronic Care equiTy by leVeraging the Telehealth Ecosystem
Ap rekrite
- Zuckerberg San Francisco General Hospital (ZSFG) & SF Department of Public Health (DPH), San Francisco
Cholesterol and Inflammation Lowering Via Bempedoic Acid, an ACL-inhibiting Regimen in HIV Trial (CLEAR HIV Trial)
Ap rekriteFaz 2
- San Francisco General Hospital, San Francisco
Supportive Training After Cardiac Rehabilitation Including Virtual Engagement
Ap rekrite
- University of California, San Francisco, San Francisco
Text Education About Cardiovascular Health and HIV (TEACH-HIV)
Ap rekrite
- Zuckerberg San Francisco General Hospital, San Francisco
- University of California San Francisco, San Francisco
Etid Maladi kadyovaskilè nan lòt vil
- Boston, MA37 etid
- New York City, NY33 etid
- Washington, DC28 etid
- Houston, TX24 etid
- Dallas, TX23 etid
- Atlanta, GA22 etid
- Cleveland, OH22 etid
- Chicago, IL21 etid
- Philadelphia, PA21 etid
- Pittsburgh, PA20 etid
- St. Louis, MO20 etid
- Nashville, TN18 etid
Lòt etid nan San Francisco
- Kansè pwostat45 etid
- Kansè nan tete43 etid
- Kansè Poumon ki pa ti selil36 etid
- Kansè (tout kalite)35 etid
- Ensifizyans kadyak29 etid
- Kansè Metastatik28 etid
- Kansè poumon22 etid
- Melanom22 etid
- Kansè pankreyas20 etid
- Kansè ovè19 etid
- Kansè kolorektal18 etid
- Gliyoblastòm17 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.